Quality indicators for the care and outcomes of adults with atrial fibrillation.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
06 04 2021
Historique:
pubmed: 30 8 2020
medline: 10 8 2021
entrez: 30 8 2020
Statut: ppublish

Résumé

To develop quality indicators (QIs) that may be used to evaluate the quality of care and outcomes for adults with atrial fibrillation (AF). We followed the ESC methodology for QI development. This methodology involved (i) the identification of the domains of AF care for the diagnosis and management of AF (by a group of experts including members of the ESC Clinical Practice Guidelines Task Force for AF); (ii) the construction of candidate QIs (including a systematic review of the literature); and (iii) the selection of the final set of QIs (using a modified Delphi method). Six domains of care for the diagnosis and management of AF were identified: (i) Patient assessment (baseline and follow-up), (ii) Anticoagulation therapy, (iii) Rate control strategy, (iv) Rhythm control strategy, (v) Risk factor management, and (vi) Outcomes measures, including patient-reported outcome measures (PROMs). In total, 17 main and 17 secondary QIs, which covered all six domains of care for the diagnosis and management of AF, were selected. The outcome domain included measures on the consequences and treatment of AF, as well as PROMs. This document defines six domains of AF care (patient assessment, anticoagulation, rate control, rhythm control, risk factor management, and outcomes), and provides 17 main and 17 secondary QIs for the diagnosis and management of AF. It is anticipated that implementation of these QIs will improve the quality of AF care.

Identifiants

pubmed: 32860039
pii: 5898806
doi: 10.1093/europace/euaa253
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

494-495

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Suleman Aktaa (S)

Leeds Institute for Data Analytics, University of Leeds, UK; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, UK.

Andreas Bollmann (A)

Department of Electrophysiology, Heart Centre Leipzig at University of Leipzig, Leipzig, Germany.

André D'Avila (A)

Cardiac Arrhythmia Service, Hospital SOS Cardio, Florianopolis, SC, Brazil; Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Inga Drossart (I)

European Society of Cardiology, Sophia Antipolis, France; ESC Patient Forum, Sophia Antipolis, France.

Jeremy Dwight (J)

ESC Patient Forum, Sophia Antipolis, France.

Mellanie True Hills (MT)

StopAfib.org, American Foundation for Women's Health, Decatur, TX, USA.

Gerhard Hindricks (G)

Department of Electrophysiology, Heart Centre Leipzig at University of Leipzig, Leipzig, Germany.

Fred M Kusumoto (FM)

Cardiology Department, Mayo Clinic Hospital, Jacksonville, FL, USA.

Deirdre A Lane (DA)

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Dennis H Lau (DH)

Centre for Heart Rhythm Disorders, The University of Adelaide and Department of Cardiology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Maddalena Lettino (M)

Cardiovascular Department, San Gerardo Hospital, ASST-Monza, Monza, Italy.

Gregory Y H Lip (GYH)

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Trudie Lobban (T)

Arrhythmia Alliance/AF Association/STARS, Chipping Norton, UK.

Hui-Nam Pak (HN)

Yonsei University Health System, Seoul, Republic of Korea.

Tatjana Potpara (T)

School of Medicine, University of Belgrade, Serbia; Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia.

Luis C Saenz (LC)

Fundación Cardio Infantil-Instituto de Cardiología, Bogotá, Colombia.

Isabelle C Van Gelder (IC)

Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.

Paul Varosy (P)

Rocky Mountain Regional Veterans Affairs Medical Center and the University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Chris P Gale (CP)

Leeds Institute for Data Analytics, University of Leeds, UK; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, UK.

Nikolaos Dagres (N)

Department of Electrophysiology, Heart Centre Leipzig at University of Leipzig, Leipzig, Germany.

Serge Boveda (S)

Clinique Pasteur, Heart Rhythm Department, 31076 Toulouse, France.

Thomas Deneke (T)

Clinic for Interventional Electrophysiology, Heart Centre RHÖN-KLINIKUM Campus Bad Neustadt, Germany.

Pascal Defaye (P)

CHU Grenoble Alpes, Unite de Rythmologie Service De Cardiologie, CS10135, 38043 Grenoble Cedex 09, France.

Giulio Conte (G)

Cardiology Department, Cardiocentro Ticino, Lugano, Switzerland.

Radoslaw Lenarczyk (R)

First Department of Cardiology and Angiology, Silesian Centre for Heart Disease, Curie-Sklodowskiej Str 9, 41-800 Zabrze, Poland.

Rui Providencia (R)

St Bartholomew's Hospital, Barts Heart Centre, Barts Health NHS Trust, London, UK and Institute of Health Informatics, University College of London, London, UK.

Jose M Guerra (JM)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Universidad Autonoma de Barcelona, CIBERCV, Barcelona, Spain.

Yoshihide Takahashi (Y)

Department of Advanced Arrhythmia Research, Tokyo Medical and Dental University, Tokyo, Japan.

Cristiano Pisani (C)

Heart Institute, Arrhythmia Unit, Sao Paulo, Brazil.

Santiago Nava (S)

Head of Electrocardiology Department, Instituto Nacional de Cardiologia 'Ignacio Chavez', Mexico.

Andrea Sarkozy (A)

University Hospital of Antwerp, University of Antwerp, Antwerp, Belgium.

Taya V Glotzer (TV)

Hackensack Meridian-Seton Hall School of Medicine, Rutgers New Jersey Medical School; Director of Cardiac Research, Hackensack University Medical Center, Hackensack, USA.

Mario Martins Oliveira (M)

Hospital Santa Marta, Department of Cardiology, Rua Santa Marta, 1167-024 Lisbon, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH